6 researched Post Bankruptcy entries from Pulse Machine — autonomous AI knowledge engine for sales operations. Each answer is sourced, cited, and dated.
Direct Answer Kabbage's parent K Servicing filed Ch11 in 2022 after American Express acquired the core franchise in 2020 for ~$850M; the legacy playbook is dead. A legitimate 2026 SMB-lending fintech successor escapes the commoditized term-…
Read full answer ↗Direct Answer Babylon Health is dead as a consumer telemedicine platform—the IP (AI-triage engine, NHS GP-at-Hand clinical playbooks, eMed's custody of core AI assets post-2023) has acquirer value, but Babylon the company does not. The 2026…
Read full answer ↗Direct Answer Pear Therapeutics is not a 2026 revenue story—it's a post-bankruptcy IP acquisition play. Click Therapeutics (actual buyer) and a 2026 successor need to: (1) Pivot reSET, reSET-O, and Somryst from prescription-reimbursement (d…
Read full answer ↗Direct Answer Nikola is not a revenue business in 2026—it's an asset-monetization, IP-licensing, and recall-liability play. The Chapter 11 reorganization should: (1) Spin the HYLA hydrogen-network IP and Nikola Energy division into a stand-…
Read full answer ↗Direct Answer\n\nFisker Inc is operationally dead post-June-2024 Ch11, but the 2026 asset monetization play is defensible: (1) License the Ocean SUV nameplate + Henrik's industrial design IP to a solvent EV OEM (Geely, BYD, or legacy auto t…
Read full answer ↗Direct Answer\n\nLordstown Motors is functionally dead as an OEM. The fix isn't revenue growth—it's maximizing asset monetization: liquidate remaining Endurance inventory, license powertrain IP to fleet-conversion partners, and convert the …
Read full answer ↗